Reframing Psoriasis Therapy: TYK2 Inhibition and the Erosion of the Oral-Biologic Divide. Ma S, Zieneldien T, Aljassabi A, Grant-Kels JM, et al. Clin Dermatol 2026 Jan 21:S0738-081X(26)00008.

Read + Share

Amedeo Smart

Independent Medical Education

Ma S, Zieneldien T, Aljassabi A, Grant-Kels JM, et al. Reframing Psoriasis Therapy: TYK2 Inhibition and the Erosion of the Oral-Biologic Divide. Clin Dermatol 2026 Jan 21:S0738-081X(26)00008.
PMID: 41577058